Nichols Joan E, Niles Jean A, Vega Stephanie P, Argueta Lissenya B, Eastaway Adriene, Cortiella Joaquin
University of Texas Medical Branch, Department of Internal Medicine, Division of Infectious Diseases, Galveston, TX 77555-0435, USA University of Texas Medical Branch, Department of Microbiology and Immunology, Galveston, TX 77555-0435, USA University of Texas Medical Branch, School of Medicine, Galveston, TX 77555-0435, USA
University of Texas Medical Branch, Department of Internal Medicine, Division of Infectious Diseases, Galveston, TX 77555-0435, USA.
Exp Biol Med (Maywood). 2014 Sep;239(9):1135-69. doi: 10.1177/1535370214536679. Epub 2014 Jun 24.
Respiratory tract specific cell populations, or tissue engineered in vitro grown human lung, have the potential to be used as research tools to mimic physiology, toxicology, pathology, as well as infectious diseases responses of cells or tissues. Studies related to respiratory tract pathogenesis or drug toxicity testing in the past made use of basic systems where single cell populations were exposed to test agents followed by evaluations of simple cellular responses. Although these simple single-cell-type systems provided good basic information related to cellular responses, much more can be learned from cells grown in fabricated microenvironments which mimic in vivo conditions in specialized microfabricated chambers or by human tissue engineered three-dimensional (3D) models which allow for more natural interactions between cells. Recent advances in microengineering technology, microfluidics, and tissue engineering have provided a new approach to the development of 2D and 3D cell culture models which enable production of more robust human in vitro respiratory tract models. Complex models containing multiple cell phenotypes also provide a more reasonable approximation of what occurs in vivo without the confounding elements in the dynamic in vivo environment. The goal of engineering good 3D human models is the formation of physiologically functional respiratory tissue surrogates which can be used as pathogenesis models or in the case of 2D screening systems for drug therapy evaluation as well as human toxicity testing. We hope that this manuscript will serve as a guide for development of future respiratory tract model systems as well as a review of conventional models.
呼吸道特定细胞群体,或体外组织工程培养的人肺,有潜力用作研究工具,以模拟细胞或组织的生理学、毒理学、病理学以及传染病反应。过去,与呼吸道发病机制或药物毒性测试相关的研究使用的是基本系统,即让单细胞群体暴露于测试剂,然后评估简单的细胞反应。尽管这些简单的单细胞类型系统提供了与细胞反应相关的良好基础信息,但从在模拟体内条件的人造微环境中生长的细胞,或通过允许细胞之间进行更自然相互作用的人体组织工程三维(3D)模型中,可以学到更多东西。微工程技术、微流体技术和组织工程的最新进展为开发二维和三维细胞培养模型提供了新方法,这些模型能够生产出更强大的体外人体呼吸道模型。包含多种细胞表型的复杂模型也能更合理地模拟体内发生的情况,而不会受到动态体内环境中混杂因素的影响。构建良好的三维人体模型的目标是形成具有生理功能的呼吸组织替代物,可将其用作发病机制模型,或在二维筛选系统中用于药物治疗评估以及人体毒性测试。我们希望这份手稿能为未来呼吸道模型系统的开发提供指导,并对传统模型进行综述。